Metropolitan Life Insurance CO Anika Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$25.91 - $32.1 $6,088 - $7,543	-235 Reduced 22.05%	831 $23,000
Q4 2022 Jun 14, 2023	BUY	$23.85 - $31.91 $5,604 - $7,498	235 Added 28.28%	1,066 $31.6 Million
Q3 2022 Jun 14, 2023	BUY	$21.74 - $24.68 $5,108 - $5,799	235 Added 28.28%	1,066 $25.4 Million
Q2 2022 Jun 20, 2023	BUY	$20.4 - $25.53 $4,794 - $5,999	235 Added 28.28%	1,066 $23,000
Q1 2022 Jun 20, 2023	BUY	$24.7 - $36.54 $5,804 - $8,586	235 Added 28.28%	1,066 $26,000
Q1 2022 Mar 30, 2023	SELL	$24.7 - $36.54 $88,475 - $130,886	-3,582 Reduced 77.07%	1,066 $26,000
Q1 2022 May 12, 2022	SELL	$24.7 - $36.54 $88,475 - $130,886	-3,582 Reduced 77.07%	1,066 $27,000
Q4 2021 Jun 21, 2023	BUY	$35.83 - $45.03 $136,763 - $171,879	3,817 Added 459.33%	4,648 $166,000
Q3 2021 Jun 21, 2023	BUY	$38.75 - $44.47 $147,908 - $169,741	3,817 Added 459.33%	4,648 $197,000
Q2 2021 Jun 21, 2023	BUY	$39.42 - $48.08 $150,466 - $183,521	3,817 Added 459.33%	4,648 $201,000
Q2 2021 Aug 16, 2021	BUY	$39.42 - $48.08 $183,027 - $223,235	4,643 Added 92860.0%	4,648 $201,000
Q1 2021 Jun 26, 2023	BUY	$32.49 - $45.96 $124,014 - $175,429	3,817 Added 459.33%	4,648 $190 Million
Q1 2021 May 14, 2021	SELL	$32.49 - $45.96 $150,851 - $213,392	-4,643 Reduced 99.89%	5 $190,000
Q4 2020 Jun 22, 2023	BUY	$32.59 - $45.26 $124,396 - $172,757	3,817 Added 459.33%	4,648 $210,000
Q3 2020 Jun 26, 2023	BUY	$32.56 - $38.57 $124,281 - $147,221	3,817 Added 459.33%	4,648 $164,000
Q2 2020 Jun 26, 2023	BUY	$27.83 - $37.73 $106,227 - $144,015	3,817 Added 459.33%	4,648 $175,000
Q2 2020 Mar 30, 2023	SELL	$27.83 - $37.73 $13,720 - $18,600	-493 Reduced 9.59%	4,648 $175,000
Q2 2020 Aug 14, 2020	SELL	$27.83 - $37.73 $13,720 - $18,600	-493 Reduced 9.59%	4,648 $175,000
Q1 2020 Jul 12, 2023	BUY	$22.38 - $54.06 $96,457 - $232,998	4,310 Added 518.65%	5,141 $148,000
Q4 2019 Jul 12, 2023	BUY	$51.85 - $73.36 $223,473 - $316,181	4,310 Added 518.65%	5,141 $266,000
Q3 2019 Jul 12, 2023	BUY	$40.05 - $57.47 $172,615 - $247,695	4,310 Added 518.65%	5,141 $282,000
Q2 2019 Jul 12, 2023	BUY	$30.3 - $41.14 $130,593 - $177,313	4,310 Added 518.65%	5,141 $208,000
Q1 2019 Jul 13, 2023	BUY	$29.37 - $40.49 $126,584 - $174,511	4,310 Added 518.65%	5,141 $155,000
Q1 2019 Mar 30, 2023	BUY	$29.37 - $40.49 $119,682 - $164,996	4,075 Added 382.27%	5,141 $155,000
Q1 2019 May 16, 2019	SELL	$29.37 - $40.49 $1.02 Million - $1.41 Million	-34,799 Reduced 87.13%	5,141 $155,000
Q1 2019 May 15, 2019	BUY	$29.37 - $40.49 $1.02 Million - $1.41 Million	34,799 Added 676.89%	39,940 $1.02 Million
Q4 2018 Jul 13, 2023	BUY	$30.16 - $43.0 $129,989 - $185,330	4,310 Added 518.65%	5,141 $172,000
Q4 2018 Feb 14, 2019	BUY	$30.16 - $43.0 $122,902 - $175,225	4,075 Added 382.27%	5,141 $173,000
Q3 2018 Jul 13, 2023	BUY	$32.83 - $42.51 $141,497 - $183,218	4,310 Added 518.65%	5,141 $217 Million
Q3 2018 Nov 14, 2018	SELL	$32.83 - $42.51 $133,782 - $173,228	-4,075 Reduced 79.26%	1,066 $45,000
Q4 2017 Feb 15, 2018	SELL	$52.14 - $59.94 $275,090 - $316,243	-5,276 Reduced 50.65%	5,141 $277,000
Q2 2017 Aug 14, 2017	BUY	N/A	10,417	10,417 $514,000

Others Institutions Holding ANIK

# of Institutions

123

Shares Held

11.5M

Call Options Held

200

Put Options Held

100

Trigran Investments, Inc.

2.12M
Shares

$34.4 Million
5.75% of portfolio
Black Rock Inc. New York, NY

1.61M
Shares

$26 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

799K
Shares

$12.9 Million
0.0% of portfolio
Dimensional Fund Advisors LP Austin, TX

707K
Shares

$11.5 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

574K
Shares

$9.3 Million
0.02% of portfolio

View Full List

About Anika Therapeutics, Inc.

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $236M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

More about ANIK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account